Nanobodies/antibodies to modulate and detect CXCR4 and CXCR7 mono-, homo-, and heteromers

Early stage researcher 3 (ESR3) project – Vladimir Bobkov
Supervision: Bas van der Woning, Michael Saunders and Hans de Haard.
Host: arGEN-X (BE)

I- Project proposal:

Aim:
1. Generate nanobodies/ SIMPLE antibodiesTM to specifically target the extracellular and intracellular site of CXCR4, CXCR7 mono-, homo-, and heteromers, in order to modulate their function or use as diagnostics.

2. Optimize the nanobodies/ SIMPLE Antibodies™ using ADCC-enhancing technology for in vivo modulation and diagnostics.

Methodology:
In order to identify nanobodies and antibodies against CXCR4 and CXCR7 llamas will be immunized with CXCR4 and CXCR7 encoding DNA and recombinant purified CXCR4 and CXCR7. Phage libraries will be generated displaying the variable domains of the antibody repertoire of the immunized llamas. Antigen specific clones will be selected by phage pannings on CXCR4/ CXCR7 bearing virus-like lipoparticles, and characterized by FACS analysis and cell-based assays. Full IgGs, optimized for inducing ADCC, will be produced for in vivo efficacy studies in mouse tumor models.

Planned secondment: VU (NL).

 

II- Requirement candidate:

Required diploma: MSc degree in molecular/biomedical Life Sciences, Pharmaceutical Sciences or related Life Science degree.

Required expertise: cell culture, cell-based assays, biochemistry and molecular biology. Recommended expertise: FACS analysis, recombinant DNA technology (PCR, restriction cloning, transformation, etc), phage display, protein purification, SDS-PAGE, working experience in industry.

Key publications:
1. Cuende J and Liénart S et al, and Lucas S (2015) Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo. Science Translational Medicine. Accepted for publication.

2. Silence K et al., and De Haard HJ (2014) ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade. MAbs 6:523-32.

3. Basilico C et al, and Michieli P (2014) Four individually druggable MET hotspots mediate HGF-driven tumor progression. J Clin Invest. 124:3172-86.

Follow us on

The transatlantic ECI GPCR symposium #ECIGPCR is about to start, we are ready!! Thanks to the organizers for their excellent job gathering almost 500 people across the globe! @cyclic_Andreas @NicoleAPerry1 @BenderSci @DesislavaNeshe1

My project will be focused on the role of #CXCR4/ACKR3/GRK2 -governed networks in cancer cell migration and metastasis.

Hello 🙂
I am here to continue the series in which all #ESRs are presenting themselves. I am Viviana Marolda and I am in my first year of PhD. I am #ESR13, originally from Italy, and currently, I am working as a PhD student in @CBMSO_CSIC_UAM, at Universidad Autonoma de Madrid.

Hey twitter!
I am @DehanComez. I am taking over the Oncornet account for a while to start a series of all #ESRs writing about themselves and their projects. I am #ESR5, originally from Turkey and right now I am working as a PhD student in @COMPARE_UoBUoN , @UniofNottingham , UK.

New review on #gpcr structural dynamics out in COSB. Great teamwork with the @JanaSelent group. Thanks to @Lundbeckfonden and @novonordiskfond https://lnkd.in/eyjrA5V

ONCORNET2.0 is the successor to #ONCORNET. You can see some of the work of ESRs from the first ONCORNET in this special issue of @MolPharmJournal from 2019, with reviews on #CXCR4 and #ACKR3 structure and function: https://molpharm.aspetjournals.org/content/96/6

Hi everyone – we’re on Twitter! ONCORNET2.0 is a #MarieCurie ITN of 16 ESRs across Europe studying #chemokine #GPCRs #CXCR4 and #ACKR3 in cancer. Our projects cover molecular dynamics, medchem, #pharmacology through to translational work. Follow us for updates from our ESRs!

Hi everyone!

Public service announcement: our Marie-Curie ITN @ONCORNET1 is on Twitter! The 16 wonderful #ECRs working on the project will soon be Tweeting about #GPCR #chemokine #ECR life and #pharmacology

Please #RT & consider a follow or follow back! 🙏😀

Load More…

Contact details

Please contact us at:
info@oncornet.eu

ONCORNET Coordinator
VU University Amsterdam
The Netherlands